Plunkett Research Online: Asterias Biotherapeutics Inc

ASTERIAS BIOTHERAPEUTICS INC (AST:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Asterias Biotherapeutics Inc is a biotechnology company engaged in developing and commercializing therapies in the fields of cell therapy and regenerative medicine. The company has two core technology platforms. The first is an immunotherapy platform to teach cancer patients immune systems to attack.....



Asterias Biotherapeutics Inc
Ticker: AST
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 510 521-3390
Fax:
Address: 6300 Dumbarton Circle
Fremont, CA 94555 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Michael MulroyCEO/Director/President
Ryan ChavezCFO/Chief Accounting Officer/General Counsel/Secretary
See More
Asterias Biotherapeutics Inc is a biotechnology company engaged in developing and commercializing therapies in the fields of cell therapy and regenerative medicine. The company has two core technology platforms. The first is an immunotherapy platform to teach cancer patients immune systems to attack.....See More See More

Auditor: OUM & Co. LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: